Since their first use for treating rheumatoid arthritis (RA) in the late 1940s, glucocorticoids
(GCs) have been representing a substantial part of the therapeutic arsenal for RA. However …

Mortality rates in patients with rheumatoid arthritis (RA) are 1.5-1.6 fold higher than in the
general population, with similar patterns over 60 years. The acute attributed causes of death …

Background Low-dose glucocorticoid (GC) therapy is widely used in rheumatoid arthritis
(RA) but the balance of benefit and harm is still unclear. Methods The GLORIA …

Objectives. The prevalence of interstitial lung disease (ILD) in RA is∼ 5%. Previous work
identified increasing age, active articular disease and articular damage as risk factors for RA …

Objectives To assess predictive factors for rheumatoid arthritis interstitial lung disease (RA-
ILD) in two early rheumatoid arthritis (RA) inception cohorts with a focus on methotrexate …

Objectives We investigated access to biologic and synthetic disease modifying drugs
(bDMARDs and sDMARDs) in patients with rheumatoid arthritis (RA) across Europe …

Introduction Gender as a predictor of outcomes of rheumatoid arthritis (RA) has evoked
considerable interest over the decades. Historically, there is no consensus whether RA is …

Introduction We analyzed the prevalence of cardiovascular (CV) disease in patients with
rheumatoid arthritis (RA) and its association with traditional CV risk factors, clinical features …

Introduction Work disability is a major consequence of rheumatoid arthritis (RA), associated
not only with traditional disease activity variables, but also more significantly with …

Objective Regular physical activity is associated with decreased morbidity and mortality.
Traditionally, patients with rheumatoid arthritis (RA) have been advised to limit physical …